Health
Pfizer vaccine can neutralise coronavirus variants first reported in UK, South Africa: Study – Hindustan Times
The research, published in the journal Nature Medicine, noted that the vaccine is effective against coronavirus variants.
The Covid-19 vaccine co-developed by the American pharmaceutical giant Pfizer and the German biotechnology company BioNTech can neutralise variants of the novel coronavirus that were first reported in the UK and South Africa, a new study suggests.
The research, published in the journal Nature Medicine, noted that the vaccine is effective against coronavirus variants carrying the N501Y and E484K mutations.
According to the scientists, including those from the University of Texas in the US, these…
-
Noosa News12 hours agoExperts share tiny home warning as interest from young people soars
-
Noosa News18 hours agoKarenia cristata species source of toxins in SA’s algal bloom, scientists believe
-
Noosa News11 hours agoExpert’s warning as tourists stunned by hundreds of sharks spotted close to shore at Moreton Island, Queensland
-
General8 hours agoConvicted mushroom murderer Erin Patterson outlines her reasons to appeal